GOLDMAN SACHS GROUP INC - VTV THERAPEUTICS INC ownership

VTV THERAPEUTICS INC's ticker is VTVT and the CUSIP is 918385105. A total of 21 filers reported holding VTV THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of VTV THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$37,000
-50.7%
24,118
-27.1%
0.00%
Q2 2021$75,000
-57.9%
33,086
-47.5%
0.00%
Q1 2021$178,000
+314.0%
62,972
+229.9%
0.00%
Q2 2020$43,000
+22.9%
19,089
+4.1%
0.00%
Q1 2020$35,000
+105.9%
18,330
+71.5%
0.00%
Q3 2019$17,000
+41.7%
10,686
-28.6%
0.00%
Q3 2018$12,000
-82.9%
14,961
-67.1%
0.00%
Q2 2018$70,00045,5180.00%
Other shareholders
VTV THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
CIM INVESTMENT MANAGEMENT INC 177,373$404,0000.12%
Winthrop Advisory Group LLC 3,024$416,0000.09%
Game Plan Financial Advisors, LLC 13,000$30,0000.02%
XTX Topco Ltd 20,045$46,0000.02%
CITIZENS FINANCIAL GROUP INC/RI 70,000$160,0000.01%
HRT FINANCIAL LP 243,250$554,0000.01%
Engineers Gate Manager LP 25,255$58,0000.00%
MARSHALL WACE, LLP 272,255$621,0000.00%
Ergoteles LLC 54,200$124,0000.00%
Tower Research Capital LLC (TRC) 38,821$89,0000.00%
View complete list of VTV THERAPEUTICS INC shareholders